117 related articles for article (PubMed ID: 7900385)
1. [Use of isoptin SR-240 in treatment of hypertension].
Knypl K; Brym E; Wacławek-Maczkowska J
Wiad Lek; 1993 Dec; 46(23-24):898-901. PubMed ID: 7900385
[TBL] [Abstract][Full Text] [Related]
2. [Isoptin-Retard 240 mg in the treatment of mild and moderate arterial hypertension].
Arabidze GG; Rogoza AN; Dmitriev VV; Metelitsa TV; Domba GIu; Sitina VK
Ter Arkh; 1993; 65(9):50-2. PubMed ID: 8303597
[TBL] [Abstract][Full Text] [Related]
3. Long-term treatment of arterial hypertension with verapamil.
Wigler I; Peer G; Soferman G; Blum M; Aviram A
Int J Clin Pharmacol Ther Toxicol; 1984 Mar; 22(3):162-6. PubMed ID: 6715085
[TBL] [Abstract][Full Text] [Related]
4. Verapamil SR and propranolol LA: a comparison of efficacy and side effects in the treatment of mild to moderate hypertension.
Bochsler JA; Simmons RL; Ward PJ; Chester PC; Latham AN
J Hum Hypertens; 1988 Mar; 1(4):305-10. PubMed ID: 3065507
[TBL] [Abstract][Full Text] [Related]
5. The effect of Isoptin SR on blood pressure, heart function and hypertrophy of left ventricle of hypertensive patients.
Qian XX; Chen AH; Deng JY; Tang XM; Liu YF; Li ZL; Ou SB; Wu ZN; Wang KR
Chin Med J (Engl); 1994 Apr; 107(4):260-4. PubMed ID: 8088192
[TBL] [Abstract][Full Text] [Related]
6. [Tests for efficacy and tolerance of isoptin SR 240 in treatment of hypertension--BISON].
Cedro K; Dłuzniewski M; Szpytma M
Wiad Lek; 1993 Dec; 46(23-24):885-92. PubMed ID: 7900383
[No Abstract] [Full Text] [Related]
7. [A new approach to the evaluation of the effectiveness of antihypertensive therapy in patients with mild and moderate arterial hypertension based on the example of isoptin retard].
Arabidze GG; Dmitriev VV; Rogoza AN
Klin Med (Mosk); 1994; 72(5):27-30. PubMed ID: 7853810
[TBL] [Abstract][Full Text] [Related]
8. Verapamil versus nifedipine in slow-release preparations for the treatment of mild to moderate hypertension.
Shamiss A; Meisel S; Nussinovitch N; Rosenthal T
J Hum Hypertens; 1990 Aug; 4(4):465-8. PubMed ID: 2258895
[TBL] [Abstract][Full Text] [Related]
9. [Isoptin SR-240 and SR-120 in ambulatory treatment of arterial hypertension].
Radziszewski A; Surynt M; Kopeć M
Przegl Lek; 1996; 53(3):166-7. PubMed ID: 8754374
[TBL] [Abstract][Full Text] [Related]
10. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension.
Hilleman DE; Mohiuddin SM; Lucas BD; Shinn B; Elsasser GN
Clin Ther; 1993; 15(6):1002-10. PubMed ID: 8111798
[TBL] [Abstract][Full Text] [Related]
11. [The TEAM study--a study of the effectiveness and tolerance of treatment of essential hypertension with a fixed combination of trandolapril and verapamil].
Widimský J; Dzúrik R
Vnitr Lek; 1998 Jun; 44(6):326-31. PubMed ID: 9820054
[TBL] [Abstract][Full Text] [Related]
12. [Nationwide drug surveillance project on slow-release nicardipine in the short-term therapy of light/moderate arterial hypertension].
Benvenuti C; Guerini Rocco C; Trezzi P
Minerva Cardioangiol; 1995 Sep; 43(9):399-408. PubMed ID: 8552269
[TBL] [Abstract][Full Text] [Related]
13. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
[TBL] [Abstract][Full Text] [Related]
14. Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients--findings from the International Verapamil SR/Trandolapril Study (INVEST).
Cooper-DeHoff RM; Aranda JM; Gaxiola E; Cangiano JL; Garcia-Barreto D; Conti CR; Hewkin A; Pepine CJ;
Am Heart J; 2006 May; 151(5):1072-9. PubMed ID: 16644338
[TBL] [Abstract][Full Text] [Related]
15. [Verapamil and hypertension--(multicenter study of the efficacy and tolerance of delayed-action verapamil in the treatment of essential hypertension)].
Kreuter U; Mühlemann M; Vogt E; Wohlwend MC
Rev Med Suisse Romande; 1990 Jun; 110(6):551-8. PubMed ID: 2195624
[No Abstract] [Full Text] [Related]
16. [Evaluation of hypotensive and antiischemic effects of a combination of dihydropyridine and non-dihydropyridine calcium antagonists in patients suffering from coronary artery disease with arterial hypertension].
Iskendeerov BG; Burmistrova LF; Berenshteĭn NV; Abramova GN; Lokhina TV; Shibaeva TM
Klin Med (Mosk); 2006; 84(11):52-6. PubMed ID: 17243612
[TBL] [Abstract][Full Text] [Related]
17. [The role of home pressure monitoring in the treatment hypertension in the practice of general medicine].
Widimský J; Balazovjech I; Lánská V
Vnitr Lek; 1999 Oct; 45(10):569-77. PubMed ID: 10951863
[TBL] [Abstract][Full Text] [Related]
18. [Comparative anti-hypertensive effectiveness and tolerance of drugs in patients with mild and moderate arterial hypertension].
Nesterov IuI; Gol'dberg GA; Detkovskaia NA
Klin Med (Mosk); 1999; 77(8):33-6. PubMed ID: 10560253
[TBL] [Abstract][Full Text] [Related]
19. Time-released garlic powder tablets lower systolic and diastolic blood pressure in men with mild and moderate arterial hypertension.
Sobenin IA; Andrianova IV; Fomchenkov IV; Gorchakova TV; Orekhov AN
Hypertens Res; 2009 Jun; 32(6):433-7. PubMed ID: 19390538
[TBL] [Abstract][Full Text] [Related]
20. [A comparison and synergy in the treatment of essential arterial hypertension].
Arcila Herrera H; Montero Cervantes L; Rivero Cárdenas NA; Osorio Guerrero MI; Flores Serrano AG; González Franco MF
Arch Inst Cardiol Mex; 1993; 63(2):133-7. PubMed ID: 8503714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
